DTE vs NRIX
DTE (DTE) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
DTE (DTE) common stock.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
DTE does not have a complete income-statement cache yet.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
DTE currently screens at market cap $0. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the DTE and NRIX stock pages for the full models.
Not investment advice.